Wilcox CR, et al. Determinants of Influenza and Pertussis Vaccination Uptake in Pregnancy: A Multi-Centre Questionnaire Study of Pregnant Women and Healthcare Professionals. Pediatr Infect Dis J. 2018 Nov 9
INTRODUCTION:
Uptake rates of antenatal vaccination remain suboptimal. Our aims were to determine: (1) the acceptability of routine vaccination among pregnant women, (2) the confidence of maternity healthcare professionals (HCPs) discussing vaccination and (3) HCP opinion regarding the optimum healthcare site for vaccine administration.
METHODS:
Separate questionnaires for pregnant women and HCPs were distributed within four NHS trusts in South England (July 2017-January 2018).
RESULTS:
Responses from 314 pregnant women and 204 HCPs (18% obstetricians, 75% midwives, 7% unidentified) were analysed. Previous/intended uptake of influenza and pertussis vaccination was 78% and 92%, respectively. The commonest reason for declining vaccination was feared side-effects for their child. White British women (79%) were significantly more accepting of influenza (85% vs. 61%, OR 3.25, 95% CI: 1.67-6.32) and pertussis vaccination (96% vs. 83%, OR 4.83, 95% CI: 1.77-13.19) compared with non-white-British women. Among HCPs, 25% were slightly or not-at-all confident discussing vaccination. Obstetricians felt significantly more confident discussing pertussis vaccination than midwives (68% vs. 55% were very/moderately confident, OR 2.05, 95% CI: 1.02-4.12). Among HCPs, 53%, 25% and 16% thought vaccines should be administered in primary care (general practice), community midwifery and in hospital, respectively.
CONCLUSION:
Misconceptions exist regarding safety/efficacy of antenatal vaccination, and framing information towards the child´s safety may increase uptake. Education of HCPs is essential, and vaccine promotion should be incorporated into routine antenatal care, with an emphasis on women from ethnic minorities. Administration of vaccines in primary care presents logistical barriers however support for alternative sites appears low among HCPs.
Uptake rates of antenatal vaccination remain suboptimal. Our aims were to determine: (1) the acceptability of routine vaccination among pregnant women, (2) the confidence of maternity healthcare professionals (HCPs) discussing vaccination and (3) HCP opinion regarding the optimum healthcare site for vaccine administration.
METHODS:
Separate questionnaires for pregnant women and HCPs were distributed within four NHS trusts in South England (July 2017-January 2018).
RESULTS:
Responses from 314 pregnant women and 204 HCPs (18% obstetricians, 75% midwives, 7% unidentified) were analysed. Previous/intended uptake of influenza and pertussis vaccination was 78% and 92%, respectively. The commonest reason for declining vaccination was feared side-effects for their child. White British women (79%) were significantly more accepting of influenza (85% vs. 61%, OR 3.25, 95% CI: 1.67-6.32) and pertussis vaccination (96% vs. 83%, OR 4.83, 95% CI: 1.77-13.19) compared with non-white-British women. Among HCPs, 25% were slightly or not-at-all confident discussing vaccination. Obstetricians felt significantly more confident discussing pertussis vaccination than midwives (68% vs. 55% were very/moderately confident, OR 2.05, 95% CI: 1.02-4.12). Among HCPs, 53%, 25% and 16% thought vaccines should be administered in primary care (general practice), community midwifery and in hospital, respectively.
CONCLUSION:
Misconceptions exist regarding safety/efficacy of antenatal vaccination, and framing information towards the child´s safety may increase uptake. Education of HCPs is essential, and vaccine promotion should be incorporated into routine antenatal care, with an emphasis on women from ethnic minorities. Administration of vaccines in primary care presents logistical barriers however support for alternative sites appears low among HCPs.
See Also:
Latest articles in those days:
- [preprint]Highly pathogenic avian influenza management in high-density poultry farming areas 15 hours ago
- [preprint]Dairy cattle herds mount a characteristic antibody response to highly pathogenic H5N1 avian influenza viruses 15 hours ago
- Intranasal influenza virus-vectored vaccine offers protection against clade 2.3.4.4b H5N1 infection in small animal models 1 days ago
- Mapping of stakeholders in avian influenza surveillance in Canada 2 days ago
- [preprint]Population Immunity to Hemagglutinin Head, Stalk and Neuraminidase of Highly Pathogenic Avian Influenza 2.3.4.4b A(H5N1) viruses in the United States and the Impact of Seasonal Influenza on 2 days ago
[Go Top] [Close Window]